Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases

E Beurel, SF Grieco, RS Jope - Pharmacology & therapeutics, 2015 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with
over 100 known substrates to deal with. How does GSK3 maintain control to selectively …

GSK-3: tricks of the trade for a multi-tasking kinase

BW Doble, JR Woodgett - Journal of cell science, 2003 - journals.biologists.com
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase found in all
eukaryotes. The enzyme is a key regulator of numerous signalling pathways, including …

GSK-3: functional insights from cell biology and animal models

O Kaidanovich-Beilin, JR Woodgett - Frontiers in molecular …, 2011 - frontiersin.org
Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved
serine/threonine protein kinase encoded in mammals by two genes that generate two …

Caught up in a Wnt storm: Wnt signaling in cancer

RH Giles, JH Van Es, H Clevers - … et Biophysica Acta (BBA)-Reviews on …, 2003 - Elsevier
The Wnt signaling pathway, named for its most upstream ligands, the Wnts, is involved in
various differentiation events during embryonic development and leads to tumor formation …

Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway

S Amit, A Hatzubai, Y Birman, JS Andersen… - Genes & …, 2002 - genesdev.cshlp.org
The Wnt pathway controls numerous developmental processes via the β-catenin–TCF/LEF
transcription complex. Deregulation of the pathway results in the aberrant accumulation of β …

Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling

VN Uversky, CJ Oldfield… - Journal of Molecular …, 2005 - Wiley Online Library
Regulation, recognition and cell signaling involve the coordinated actions of many players.
To achieve this coordination, each participant must have a valid identification (ID) that is …

GSK-3 inhibitors: preclinical and clinical focus on CNS

H Eldar-Finkelman, A Martinez - Frontiers in molecular neuroscience, 2011 - frontiersin.org
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has
become an important strategy for treating neurodegenerative and psychiatric disorders. The …

Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence

HM Chow, M Shi, A Cheng, Y Gao, G Chen… - Nature …, 2019 - nature.com
Prediabetes and Alzheimer's disease both increase in prevalence with age. The former is a
risk factor for the latter, but a mechanistic linkage between them remains elusive. We show …

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: evidence for autoregulation of GSK-3

F Zhang, CJ Phiel, L Spece, N Gurvich… - Journal of Biological …, 2003 - ASBMB
Glycogen synthase kinase-3 (GSK-3) is a critical, negative regulator of diverse signaling
pathways. Lithium is a direct inhibitor of GSK-3 and has been widely used to test the putative …

Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

A Martinez, A Castro, I Dorronsoro… - Medicinal research …, 2002 - Wiley Online Library
Abstract Glycogen synthase kinase 3 (GSK‐3) was initially described as a key enzyme
involved in glycogen metabolism, but is now known to regulate a diverse array of cell …